Erlangen, Germany

Thomas Mertelmeier

This inventor holds 56 USPTO granted patents and 12 published patent applications and 9 EPO patents, primarily in X-Ray Imaging (CPC class A61B). Top assignees: Siemens Aktiengesellschaft, Siemens Healthcare Gmbh, Siemens Akitengesellschaft. Active years: 2000-2022.

USPTO Granted Patents = 56 

% Patents Active = 71.4

 

Average Co-Inventor Count = 2.5

ph-index = 15

Forward Citations = 1,080(Granted Patents)

Forward Citations (Not Self Cited) = 1,045(Dec 10, 2025)


Inventors with similar research interests:


Company Filing History:


Years Active: 2000-2022

Loading Chart...
Loading Chart...
Areas of Expertise:
X-Ray Imaging
Mammography Systems
Tomosynthesis
Image Reconstruction
3D Imaging
Phase Contrast
Contrast Medium
Diagnostic Apparatus
Interferometric Imaging
Tissue Monitoring
Digital Imaging
Medical Instruments
56 patents (USPTO):Explore Patents

Title: Thomas Mertelmeier - Innovative Inventor from Erlangen

Introduction: Thomas Mertelmeier is a renowned inventor hailing from Erlangen, Germany, known for his groundbreaking contributions to various technological fields.

Latest Patents: Thomas Mertelmeier holds several patents in the areas of medical devices, renewable energy, and telecommunications, showcasing his diverse range of expertise and innovation.

Career Highlights: With a career spanning over two decades, Thomas Mertelmeier has worked with leading research institutions and companies, consistently pushing the boundaries of technology through his inventive solutions.

Collaborations: Throughout his career, Thomas Mertelmeier has collaborated with top universities, research institutions, and multinational corporations, fostering a culture of innovation and knowledge exchange.

Conclusion: Thomas Mertelmeier's passion for innovation and his relentless pursuit of technological advancement have solidified his reputation as a pioneering inventor in the global innovation landscape.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…